<ѻý>Ablation Bests Drugs for Ventricular Tachycardia After Heart Attackѻý> VANISH2 trial may set new standard of care for ischemic cardiomyopathy patients Nov 16, 2024
<ѻý>Intensive Blood Pressure Control Benefits People With Type 2 Diabetes Tooѻý> BPROAD trial replicates SPRINT trial findings in diabetes population in China Nov 16, 2024
<ѻý>Making the Alzheimer’s Disease Diagnosisѻý> History, symptoms, and cognitive tests form diagnostic backbone with imaging, biomarkers for some Nov 04, 2024
<ѻý>For Your Patients: The Stages of Alzheimer’s Diseaseѻý> The disease follows a predictable trajectory through mild, moderate, and severe symptoms Nov 04, 2024
<ѻý>Cardiac Arrest Drug Administration Route a Toss Upѻý> Two randomized trials compared intraosseous and intravenous routes for the initial access attempt Oct 31, 2024
<ѻý>SGLT2 Inhibitor Carry-Over Benefits Last How Long?ѻý> Trial follow-up defines the need for long-term treatment in protecting the kidneys and heart Oct 29, 2024
<ѻý>Kidney Disease Genetic Risk Common in West Africansѻý> Observational study points to genetic risk allele dose-response Oct 29, 2024
<ѻý>Kidney Transplant Trouble Spelled Out for Newer Rejection Episode Categoriesѻý> Study details an intermediate prognosis with newer microvascular inflammation phenotypes Oct 25, 2024
<ѻý>Stroke Prevention Guideline Adds Recs for GLP-1 Drugs, Gender-Affirming Careѻý> Recommendation updates also address social determinants of health Oct 21, 2024
<ѻý>Primary Prevention in Hypercholesterolemiaѻý> Risk prediction tools, risk enhancing factors, and the impact of lifestyle Sep 30, 2024